Company / Current Liabilities per Share
Compass Therapeutics, Inc. Current Liabilities per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.06
FY2024
5-year range
$0.06 / $0.33
FY2020-FY2024
Trend
+5.4%
vs FY2023
Sector context
#208 of 210
Health Care
What the data says
Among 210 Health Care companies, Compass Therapeutics, Inc. is in the top 1% for current liabilities per share. Current Liabilities per Share returned to growth in FY2024 after 4 years of decline, reaching $0.06.
Based on SEC 10-K filings.
0.06 in FY2024 with a 5-year CAGR of -46.5%.
Improved from $0.13 to $0.06 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -27.5%
- 5-Year CAGR
- -46.5%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 210This company $0.06 Sector average $23.75
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 5.4% year-over-year.
- Ranks #208 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.06 | +5.4% |
| FY2023 | $0.06 | -52.3% |
| FY2022 | $0.13 | -24.3% |
| FY2021 | $0.17 | -48.5% |
| FY2020 | $0.33 | -77.6% |
| FY2019 | $1.47 | +21125.0% |
| FY2018 | $0.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026